It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2015.
2015 | Chennai, Tamil Nadu, India | ActiveSthree Pharmaceuticals Private Limited, a active private limited company, was established on 13 August 2015 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24297TN2015PTC101802. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹6.00 Cr.
It upholds a compliant status. Its leadership includes Ayyavu Rajavel (Director), Jayanthy Ayyavu Shanmugam (Director), Shanmugam Muthusamy (Director). Past directors included Duraisamy. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Sf No. 534/4A2B, Chettinadu Hospital Road, Padur, Chennai, Tamil Nadu, 603103.
U24297TN2015PTC101802
101802
13 August 2015
₹6.00 Cr
₹6.00 Cr
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Sthree Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ayyavu Rajavel | Director | 06 Oct 2017 | Current |
| Jayanthy Ayyavu Shanmugam | Director | 06 Oct 2017 | Current |
| Shanmugam Muthusamy | Director | 06 Oct 2017 | Current |
| Duraisamy Sengottuvelu | Director | 13 Aug 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Oct 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sthree Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 99.73% decrease. The company also saw a substantial improvement in profitability, with a 100.29% increase in profit. The company's net worth moved up by a moderate rise of 0.01%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Sthree Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Sthree Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Sthree Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sthree Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Sthree Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Sthree Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.
Progress on Ayyavu Rajavel was appointed as a Director was appointed as a Director on 06 Oct 2017 & has been associated with this company since 8 years 1 month . was documented.
Jayanthy Ayyavu Shanmugam was appointed as a Director was appointed as a Director on 06 Oct 2017 & has been associated with this company since 8 years 1 month . was recorded as a recent event.
The activity Shanmugam Muthusamy was appointed as a Director was appointed as a Director on 06 Oct 2017 & has been associated with this company since 8 years 1 month . was completed.
Progress on Duraisamy Sengottuvelu was appointed as a Director was appointed as a Director on 13 Aug 2015 & has been associated with this company since 10 years 3 months . was documented.
The CIN of Sthree Pharmaceuticals Private Limited is U24297TN2015PTC101802.
Sthree Pharmaceuticals Private Limited is headquartered at Sf No. 534/4A2B, Chettinadu Hospital Road, Padur, Chennai, Tamil Nadu, 603103.
Sthree Pharmaceuticals Private Limited was incorporated on 13 August 2015.
The current directors of Sthree Pharmaceuticals Private Limited are
The primary industry of Sthree Pharmaceuticals Private Limited is Trade.
Sthree Pharmaceuticals Private Limited is unlisted.
The authorized capital of Sthree Pharmaceuticals Private Limited is ₹6.00 Cr, and the paid-up capital is ₹6.00 Cr.
The compliance status of Sthree Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX